• Mutation; HGNC; 6770; SMAD4; Simple; p.Tyr162fs*3; Zygosity=Hemizygous (PubMed=9892110).
  

PubMed=9892110; DOI=10.1002/(SICI)1098-2264(199901)24:1<62::AID-GCC9>3.0.CO;2-4
Jonson T., Gorunova L., Dawiskiba S., Andren-Sandberg A., Stenman G., ten Dijke P., Johansson B., Hoglund M.
Molecular analyses of the 15q and 18q SMAD genes in pancreatic cancer.
Genes Chromosomes Cancer 24:62-71(1999)

PubMed=15126341; DOI=10.1158/0008-5472.CAN-03-3159
Heidenblad M., Schoenmakers E.F.P.M., Jonson T., Gorunova L., Veltman J.A., van Kessel A.G., Hoglund M.
Genome-wide array-based comparative genomic hybridization reveals multiple amplification targets and novel homozygous deletions in pancreatic carcinoma cell lines.
Cancer Res. 64:3052-3059(2004)

PubMed=15688027; DOI=10.1038/sj.onc.1208383
Heidenblad M., Lindgren D., Veltman J.A., Jonson T., Mahlamaki E.H., Gorunova L., van Kessel A.G., Schoenmakers E.F.P.M., Hoglund M.
Microarray analyses reveal strong influence of DNA copy number alterations on the transcriptional patterns in pancreatic cancer: implications for the interpretation of genomic amplifications.
Oncogene 24:1794-1801(2005)